Status:
COMPLETED
Patient-Centered Medication Adherence Intervention for Schizophrenia
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Schizophrenia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Efficacious antipsychotic medication treatments for schizophrenia are available; however , antipsychotic regimens frequently do not achieve their potential because of poor medication adherence. To dat...
Detailed Description
BFM intervention refinement will be accomplished in five phases. Phase one will include reducing the number of items in the BFM checklist by administering the expanded checklist to at least 50 patient...
Eligibility Criteria
Inclusion
- medical chart diagnosis of schizophrenia or schizoaffective disorder;
- currently prescribed outpatient antipsychotic medication (oral or depot);
- patient must have adequate capacity to provide informed consent, understand the nature of the study, and sign an informed consent document.
Exclusion
- \- significant cognitive impairment as indicated by a score \> 10 on the Blessed Orientation-Memory-Concentration (BOMC) Test.
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00144027
Start Date
December 1 2004
End Date
July 1 2009
Last Update
April 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
No. Little Rock, Arkansas, United States, 72114-1706